TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling

Science Translational Medicine

Volumn 6, Issue 227, 2014, Pages

  Cooley, Brian C ^a,j   Nevado, Jose ^b,c   Mellad, Jason ^d   Yang, Dan ^c   St Hilaire, Cynthia ^c   Negro, Alejandra ^c   Fang, Fang ^c   Chen, Guibin ^c   San, Hong ^c   Walts, Avram D ^c   Schwartzbeck, Robin L ^c   Taylor, Brandi ^c   Lanzer, Jan D ^c   Wragg, Andrew ^c,d   Elagha, Abdalla ^c,e   Beltran, Leilani E ^c   Berry, Colin ^c,f   Feil, Robert ^g   Virmani, Renu ^h   Ladich, Elena ^h   Kovacic, Jason C ^c,i   Boehm, Manfred ^c   more..

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e CAIRO UNIVERSITY   (Egypt)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h CVPATH INSTITUTE   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CD31 ANTIGEN; ENDOGLIN; NERVE CELL ADHESION MOLECULE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VIVO STUDY; LACZ GENE; MOLECULAR DYNAMICS; MORPHOLOGY; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VEIN GRAFT; YFP GENE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL LINEAGE; CELL TRANSDIFFERENTIATION; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MESODERM; MICE; NEOINTIMA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VEINS;

EID: 84897521932     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006927     Document Type: Article

References (40)

1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones, R. J. Adams, J. D. Berry, T. M. Brown, M. R. Carnethon, S. Dai, G. De Simone, E. S. Ford, C. S. Fox, H. J. Fullerton, C. Gillespie, K. J. Greenlund, S. M. Hailpern, J. A. Heit, P. M. Ho, V. J. Howard, B. M. Kissela, S. J. Kittner, D. T. Lackland, J. H. Lichtman, L. D. Lisabeth, D. M. Makuc, G. M. Marcus, A. Marelli, D. B. Matchar, M. M. McDermott, J. B. Meigs, C. S. Moy, D. Mozaffarian, M. E. Mussolino, G. Nichol, N. P. Paynter, W. D. Rosamond, P. D. Sorlie, R. S. Stafford, T. N. Turan, M. B. Turner, N. D. Wong, J. Wylie-Rosett; American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics-2011 Update: A report from the American Heart Association. Circulation 123, e18-e209 (2011).
2. R. H. Mehta, T. B. Ferguson, R. D. Lopes, G. E. Hafley, M. J. Mack, N. T. Kouchoukos, C. M. Gibson, R. A. Harrington, R. M. Califf, E. D. Peterson, J. H. Alexander; Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Investigators, Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: One-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. Circulation 124, 280-288 (2011).
3. A. K. Mitra, D. M. Gangahar, D. K. Agrawal, Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol. Cell Biol. 84, 115-124 (2006).
4. Kip1-dependent mechanism. J. Clin. Invest. 114, 419-426 (2004).
5. Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice. J. Clin. Invest. 118, 2050-2061 (2008).
6. J. C. Kovacic, R. Gupta, A. C. Lee, M. Ma, F. Fang, C. N. Tolbert, A. D. Walts, L. E. Beltran, H. San, G. Chen, C. St Hilaire, M. Boehm, Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J. Clin. Invest. 120, 303-314 (2010).
7. J. F. Bentzon, C. Weile, C. S. Sondergaard, J. Hindkjaer, M. Kassem, E. Falk, Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 26, 2696-2702 (2006).
8. A. T. Nguyen, D. Gomez, R. D. Bell, J. H. Campbell, A. W. Clowes, G. Gabbiani, C. M. Giachelli, M. S. Parmacek, E. W. Raines, N. J. Rusch, M. Y. Speer, M. Sturek, J. Thyberg, D. A. Towler, M. C. Weiser-Evans, C. Yan, J. M. Miano, G. K. Owens, Smooth muscle cell plasticity: Fact or fiction? Circ. Res. 112, 17-22 (2013).
9. J. C. Kovacic, N. Mercader, M. Torres, M. Boehm, V. Fuster, Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: From cardiovascular development to disease. Circulation 125, 1795-1808 (2012).
10. M. Zeisberg, C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore, R. Kalluri, Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337-23347 (2007).
11. D. Medici, E. M. Shore, V. Y. Lounev, F. S. Kaplan, R. Kalluri, B. R. Olsen, Conversion of vascular endothelial cells into multipotent stem-like cells. Nat. Med. 16, 1400-1406 (2010).
12. P. Y. Chen, L. Qin, C. Barnes, K. Charisse, T. Yi, X. Zhang, R. Ali, P. P. Medina, J. Yu, F. J. Slack, D. G. Anderson, V. Kotelianski, F. Wang, G. Tellides, M. Simons, FGF regulates TGF-β signaling and endothelial-to- mesenchymal transition via control of let-7 miRNA expression. Cell Rep. 2, 1684-1696 (2012).
13. L. Maddaluno, N. Rudini, R. Cuttano, L. Bravi, C. Giampietro, M. Corada, L. Ferrarini, F. Orsenigo, E. Papa, G. Boulday, E. Tournier-Lasserve, F. Chapon, C. Richichi, S. F. Retta, M. G. Lampugnani, E. Dejana, EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496 (2013).
14. Y. Y. Kisanuki, R. E. Hammer, J. Miyazaki, S. C. Williams, J. A. Richardson, M. Yanagisawa, Tie2-Cre transgenic mice: A new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242 (2001).
15. P. Soriano, Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
16. S. Srinivas, T. Watanabe, C. S. Lin, C. M. William, Y. Tanabe, T. M. Jessell, F. Costantini, Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
17. J. R. Göthert, S. E. Gustin, M. A. Hall, A. R. Green, B. Göttgens, D. J. Izon, C. G. Begley, In vivo fate-tracing studies using the Scl stem cell enhancer: Embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105, 2724-2732 (2005).
18. E. M. Zeisberg, O. Tarnavski, M. Zeisberg, A. L. Dorfman, J. R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W. T. Pu, A. B. Roberts, E. G. Neilson, M. H. Sayegh, S. Izumo, R. Kalluri, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961 (2007).
19. E. M. Zeisberg, S. E. Potenta, H. Sugimoto, M. Zeisberg, R. Kalluri, Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282-2287 (2008).
20. B. C. Cooley, Murine model of neointimal formation and stenosis in vein grafts. Arterioscler. Thromb. Vasc. Biol. 24, 1180-1185 (2004).
21. A. Ehsan, M. J. Mann, G. Dell'Acqua, K. Tamura, R. Braun-Dullaeus, V. J. Dzau, Endothelial healing in vein grafts: Proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 105, 1686-1692 (2002).
22. S. Ohtsuki, N. Kamiya, S. Hori, T. Terasaki, Vascular endothelium-selective gene induction by Tie2 promoter/enhancer in the brain and retina of a transgenic rat. Pharm. Res. 22, 852-857 (2005).
23. S. Kühbandner, S. Brummer, D. Metzger, P. Chambon, F. Hofmann, R. Feil, Temporally controlled somatic mutagenesis in smooth muscle. Genesis 28, 15-22 (2000).
24. B. Holifield, T. Helgason, S. Jemelka, A. Taylor, S. Navran, J. Allen, C. Seidel, Differentiated vascular myocytes: Are they involved in neointimal formation? J. Clin. Invest. 97, 814-825 (1996).
25. J. S. Huang, Y. H. Wang, T. Y. Ling, S. S. Chuang, F. E. Johnson, S. S. Huang, Synthetic TGF-β antagonist accelerates wound healing and reduces scarring. FASEB J. 16, 1269-1270 (2002).
26. Z. Jiang, P. Yu, M. Tao, C. Fernandez, C. Ifantides, O. Moloye, G. S. Schultz, C. K. Ozaki, S. A. Berceli, TGF-β- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling. Am. J. Physiol. Heart Circ. Physiol. 293, H482-H488 (2007).
27. Z. Jiang, M. Tao, K. A. Omalley, D. Wang, C. K. Ozaki, S. A. Berceli, Established neointimal hyperplasia in vein grafts expands via TGF-β-mediated progressive fibrosis. Am. J. Physiol. Heart Circ. Physiol. 297, H1200-H1207 (2009).
28. M. Zeisberg, J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, R. Kalluri, BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968 (2003).
29. M. J. Goumans, Z. Liu, P. Ten Dijke, TGF-β signaling in vascular biology and dysfunction. Cell Res. 19, 116-127 (2009).
30. Y. Shi, J. Massagué, Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003).
31. M. Hirasawa, K. Noda, S. Noda, M. Suzuki, Y. Ozawa, K. Shinoda, M. Inoue, Y. Ogawa, K. Tsubota, S. Ishida, Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. Mol. Vis. 17, 1222-1230 (2011).
32. D. Medici, S. Potenta, R. Kalluri, Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem. J. 437, 515-520 (2011).
33. J. P. Habashi, D. P. Judge, T. M. Holm, R. D. Cohn, B. L. Loeys, T. K. Cooper, L. Myers, E. C. Klein, G. Liu, C. Calvi, M. Podowski, E. R. Neptune, M. K. Halushka, D. Bedja, K. Gabrielson, D. B. Rifkin, L. Carta, F. Ramirez, D. L. Huso, H. C. Dietz, Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117-121 (2006).
34. P. Yu, B. T. Nguyen, M. Tao, C. Campagna, C. K. Ozaki, Rationale and practical techniques for mouse models of early vein graft adaptations. J. Vasc. Surg. 52, 444-452 (2010).
35. Y. Hu, M. Mayr, B. Metzler, M. Erdel, F. Davison, Q. Xu, Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ. Res. 91, e13 (2002).
36. L. Zhang, N. J. Freedman, L. Brian, K. Peppel, Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler. Thromb. Vasc. Biol. 24, 470-476 (2004).
37. B. S. Brooke, J. P. Habashi, D. P. Judge, N. Patel, B. Loeys, H. C. Dietz III, Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 358, 2787-2795 (2008).
38. J. R. Hoch, V. K. Stark, W. D. Turnipseed, The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J. Vasc. Surg. 22, 51-58 (1995).
39. D. E. Arking, M. J. Junttila, P. Goyette, A. Huertas-Vazquez, M. Eijgelsheim, M. T. Blom, C. Newton-Cheh, K. Reinier, C. Teodorescu, A. Uy-Evanado, N. Carter-Monroe, K. S. Kaikkonen, M. L. Kortelainen, G. Boucher, C. Lagacé, A. Moes, X. Zhao, F. Kolodgie, F. Rivadeneira, A. Hofman, J. C. Witteman, A. G. Uitterlinden, R. F. Marsman, R. Pazoki, A. Bardai, R. W. Koster, A. Dehghan, S. J. Hwang, P. Bhatnagar, W. Post, G. Hilton, R. J. Prineas, M. Li, A. Köttgen, G. Ehret, E. Boerwinkle, J. Coresh, W. H. Kao, B. M. Psaty, G. F. Tomaselli, N. Sotoodehnia, D. S. Siscovick, G. L. Burke, E. Marbán, P. M. Spooner, L. A. Cupples, J. Jui, K. Gunson, Y. A. Kesäniemi, A. A. Wilde, J. C. Tardif, C. J. O'Donnell, C. R. Bezzina, R. Virmani, B. H. Stricker, H. L. Tan, C. M. Albert, A. Chakravarti, J. D. Rioux, H. V. Huikuri, S. S. Chugh, Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLOS Genet. 7, e1002158 (2011).
40. Y. Liu, M. H. Festing, M. Hester, J. C. Thompson, M. Weinstein, Generation of novel conditional and hypomorphic alleles of the Smad2 gene. Genesis 40, 118-123 (2004).